Literature DB >> 15763717

Standard of care: promoting antiretroviral adherence in clinical care.

Jennifer J Harman1, K Rivet Amico, Blair T Johnson.   

Abstract

Although there has long been demand for programs and procedures that support or enhance adherence to antiretroviral therapy (ART) among HIV+ patients, there is scant evidence about the extent to which medical clinics have been able to incorporate adherence interventions into their standard care. A survey of clinical care settings in New York and Connecticut indicated that the current standard of care is to provide only minimal levels of adherence services, with ad hoc adherence support being offered on an as-needed basis, often by overburdened primary care staff. These results suggest a strong need for the development of ART adherence interventions that are not only easily translatable to real-life clinical settings, but also offer an organized compendium of resources for HIV+ patients, from initiation to maintenance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763717     DOI: 10.1080/09540120512331325707

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  10 in total

1.  Lessons learned from an HIV adherence pilot study in the Deep South.

Authors:  Deborah J Konkle-Parker; Judith A Erlen; Patricia M Dubbert
Journal:  Patient Educ Couns       Date:  2009-06-26

2.  Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort.

Authors:  B Biswas; E Spitznagel; A C Collier; B B Gelman; J C McArthur; S Morgello; J A McCutchan; D B Clifford
Journal:  J HIV AIDS Soc Serv       Date:  2014-01-01

3.  Predictors of poor adherence among people on antiretroviral treatment in Cape Town, South Africa: a case-control study.

Authors:  Sarah Dewing; Cathy Mathews; Mark Lurie; Ashraf Kagee; Trishanta Padayachee; Carl Lombard
Journal:  AIDS Care       Date:  2015-01-03

4.  Improving HIV/AIDS care through treatment advocacy: going beyond client education to empowerment by facilitating client-provider relationships.

Authors:  Matt G Mutchler; Glenn Wagner; Burt O Cowgill; Tara McKay; Brian Risley; Laura M Bogart
Journal:  AIDS Care       Date:  2011-01

5.  Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South.

Authors:  Deborah J Konkle-Parker; Judith A Erlen; Patricia M Dubbert; Warran May
Journal:  J Am Acad Nurse Pract       Date:  2012-04-30

6.  Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV.

Authors:  Ira B Wilson; Michael Barton Laws; Steven A Safren; Yoojin Lee; Minyi Lu; William Coady; Paul R Skolnik; William H Rogers
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

7.  HIV Standard of Care for ART Adherence and Retention in Care Among HIV Medical Care Providers Across Four CNICS Clinics in the US.

Authors:  Sarah Shaw; Riddhi Modi; Michael Mugavero; Carol Golin; Evelyn Byrd Quinlivan; Laramie R Smith; Katya Roytburd; Heidi Crane; Jeanne Keruly; Anne Zinski; K Rivet Amico
Journal:  AIDS Behav       Date:  2019-04

8.  A Mobile App for Chronic Disease Self-Management: Protocol for a Randomized Controlled Trial.

Authors:  Raymond L Ownby; Amarilis Acevedo; Drenna Waldrop-Valverde; Joshua Caballero; Michael Simonson; Rosemary Davenport; Kofi Kondwani; Robin J Jacobs
Journal:  JMIR Res Protoc       Date:  2017-04-05

9.  Development of a computerized intervention to improve health literacy in older Hispanics with type 2 diabetes using a pharmacist supervised comprehensive medication management.

Authors:  Joshua Caballero; Robin J Jacobs; Raymond L Ownby
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

10.  Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence.

Authors:  Raymond L Ownby; Drenna Waldrop-Valverde; Robin J Jacobs; Amarilis Acevedo; Joshua Caballero
Journal:  BMC Med Inform Decis Mak       Date:  2013-02-28       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.